Clinical Trial Update: Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4) [Phase 3]

View source ↗

Summary

Phase 3 trial DUBLIN-4 compares docetaxel plus plinabulin vs docetaxel plus placebo in advanced/metastatic non-squamous non-small cell lung cancer after PD-1/PD…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Plinabulin (plinabulin)

Snippet

Sponsor: BeyondSpring Pharmaceuticals Inc. | Conditions: Non-Small Cell Lung Cancer, Non-squamous Non-Small Cell Lung Cance | Phase 3 | Status: NOT_YET_RECRUITING